StonvexLoading…
StonvexStonvexStonvexCore line items from SNDX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $172.35M | $23.68M | $0.00 | $0.00 |
Operating Income | $-273.08M | $-339.67M | $-229.95M | $-151.76M |
Net Income | $-285.42M | $-318.76M | $-209.36M | $-149.34M |
EPS (Diluted) | $-3.29 | $-3.72 | $-2.98 | $-2.46 |
Total Assets | $529.71M | $724.82M | $612.88M | $497.24M |
Total Liabilities | $465.08M | $436.69M | $58.68M | $29.79M |
Cash & Equivalents | $134.93M | $154.08M | $295.39M | $74.36M |
Free Cash Flow OCF − CapEx | $-323.17M | $-274.90M | $-160.60M | $-133.68M |
Shares Outstanding | 87.41M | 85.69M | 84.83M | 68.11M |